Neuron23

Neuron23

Biotechnology Research

South San Francisco, California 4,272 followers

We are a biotech company focused on developing precision medicines for neurological and immunological diseases.

Über uns

Neuron23™ Inc. is a leading clinical-stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunological diseases. Neuron23 combines recent advances in human genetics with a state-of-the-art drug discovery and biomarker platform using advanced techniques in machine learning and artificial intelligence to advance therapeutics for devastating diseases. The Company’s focus areas are neurodegenerative diseases, neuroinflammatory diseases, and systemic autoimmune and inflammatory diseases. Founded in 2018, Neuron23 has assembled a world-class team of experts and entrepreneurs located in South San Francisco, CA.

Website
https://neuron23.com
Industrie
Biotechnology Research
Größe des Unternehmens
51-200 Mitarbeiter
Hauptsitz
South San Francisco, California
Typ
In Privatbesitz
Gegründet
2018
Spezialitäten
biotech, precision medicine, immunological diseases, neurological diseases, neurodegenerative diseases, neuroinflammatory diseases, autoimmune diseases, inflammatory diseases, human genetics, data science, Parkinson's disease, Crohn's disease, Ulcerative colitis, psoriasis, IBD, and ankylosing spondylitis

Standorte

Employees at Neuron23

Aktualisierungen

Ähnliche Seiten

Jobs durchsuchen

Finanzierung

Neuron23 4 total rounds

Letzte Runde

Series C

US$ 100.0M

Siehe mehr Informationen auf crunchbase